Finance

Lists
Why is HEPA down 50,61%?
Dive Deeper
HEPA:OTCMKTS
Hepion Pharmaceuticals Inc
USD 0,061
-50,61%
(-0,062) 1D
13 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HEPA...
Open
USD 0,12
High
USD 0,13
Low
USD 0,06
Mkt. cap
7,74 m
Avg. vol.
35,78 k
Volume
72,12 k
52-wk high
USD 0,13
52-wk low
USD 0,03
EPS
-USD 0,24
Beta
1,75
Shares outstanding
98,22 m
No. of employees
2
Open
USD 0,12
High
USD 0,13
Low
USD 0,06
Mkt. cap
7,74 m
Avg. vol.
35,78 k
Volume
72,12 k
52-wk high
USD 0,13
52-wk low
USD 0,03
EPS
-USD 0,24
Beta
1,75
Shares outstanding
98,22 m
No. of employees
2
News stories
From web sources and news partners
About Hepion Pharmaceuticals Inc
CEO-
Employees2
Founded2013
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
70,00 k
50,92 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
527,90 k
609,68 k
728,51 k
1,16 m
Operating expense
527,90 k
609,68 k
798,51 k
1,21 m
Total operating expenses
527,90 k
609,68 k
798,51 k
1,21 m
Operating income
-527,90 k
-609,68 k
-798,51 k
-1,21 m
Other non operating income
-
-
-10,15 k
-42,99 k
EBT including unusual items
-472,51 k
-656,88 k
-810,79 k
-1,25 m
EBT excluding unusual items
-519,79 k
-622,26 k
-810,79 k
-1,25 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-472,51 k
-656,88 k
-810,79 k
-1,25 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8,12 k
-
-
6,24 k
Interest expense
-
-12,58 k
-2,13 k
-
Net interest expenses
8,12 k
-12,58 k
-2,13 k
6,24 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-520,21 k
-601,99 k
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme